An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6601538.pdf
Reference33 articles.
1. Banasiak D, Barneston AR, Odell RA, Mameghan H, Russell PJ (1999) Comparison between the clonogenic, MT and SRB assay for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line. Radiat Oncol Invest 7: 77–85
2. Blandy JP, England HR, Evans SJW, Hope-Stone HF, Mair GMM, Mantell BS, Oliver RT, Paris AMI, Risdon RA (1980) T3 bladder cancer–the case for salvage cystectomy. Br J Urol 52: 506–510
3. Cappella P, Tomasoni D, Faretta M, Lupi M, Montalenti F, Viale F, Banzato F, D’Incalci M, Ubezio P (2001) Cell cycle effects of gemcitabine. Int J Cancer 93: 401–408
4. Chen M, Hough AM, Lawrence TS (2000) The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization. Cancer Chemother Pharmacol 45: 369–374
5. Fechner G, Perabo FGE, Schimdt DH, Haase L, Ludwig HE, Schueller H, Blatter J, Muller SC, Albers P (2003) Preclinical evaluation of radiosensitising effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells. Urology 61(2): 468–473
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A narrative review of management of muscle-invasive bladder cancer perioperative period: will continuous and combined treatment be the new trend?;Translational Andrology and Urology;2024-02
2. Review of Experimental Studies to Improve Radiotherapy Response in Bladder Cancer: Comments and Perspectives;Cancers;2020-12-30
3. Bladder-sparing strategies for invasive bladder cancer;Advances in Bladder Cancer Management;2015-10
4. Combined Chemoradiation Therapy With Twice-Weekly Gemcitabine and Cisplatin for Organ Preservation in Muscle-Invasive Bladder Cancer: Long-Term Results of a Phase 1 Trial;International Journal of Radiation Oncology*Biology*Physics;2014-03
5. Trimodality treatment in the conservative management of infiltrating bladder cancer: A critical review of the literature;Critical Reviews in Oncology/Hematology;2013-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3